The $50 fine print

A $50 monthly price is finally real for some Medicare-covered weight-loss drugs. The useful part is knowing whether the new program actually fits you before a pharmacy counter, an ad, or an old rejection sends you in the wrong direction.

The rules are specific, but they are manageable. Start with your Medicare drug coverage, your health history, and one conversation with the clinician who knows that history.

MEDICARE

Medicare's $50 weight-loss drug program has strict rules

Medicare’s new GLP-1 Bridge is now open nationwide. Since July 1, eligible people with Medicare drug coverage have been able to get certain weight-loss drugs for $50 per month. The temporary program runs through December 31, 2027 (Medicare’s coverage guide).

That is a meaningful change. Medicare drug plans have generally covered GLP-1 medicines when used for certain other medical conditions, not weight loss by itself. The Bridge creates a separate route for people who meet its weight and health rules.

My protective read is this: do not hear “Medicare covers weight-loss drugs” and assume every medicine, diagnosis, or prescription qualifies. This is a defined program with a defined list. If you fit, $50 can make treatment far more reachable. If you do not, an online ad cannot rewrite Medicare’s rules.

Start with eligibility

You must be 18 or older and enrolled in Medicare drug coverage. That can be a stand-alone Part D plan, a Medicare Advantage plan with drug coverage, a Special Needs Plan, an employer or union Medicare drug plan, or Medicare’s temporary drug coverage for certain low-income enrollees.

You must also meet one of these three tests when you start treatment:

• Body mass index of 35 or higher: No additional condition is listed for this tier.
• Body mass index of 30 or higher: You must also have diastolic heart failure, uncontrolled high blood pressure, or chronic kidney disease at stage 3a or higher.
• Body mass index of 27 or higher: You must also have prediabetes, a previous heart attack or stroke, or symptomatic blocked arteries in your arms or legs.

Those are Medicare’s categories, not a general medical judgment about who might benefit from treatment. Your clinician should confirm your current body mass index, the exact diagnosis in your record, and whether a GLP-1 medicine is appropriate for you. Medicare’s page includes an eligibility questionnaire, but it is a starting screen—not an approval.

The covered list is narrow

The program currently covers three drug families, and formulation matters:

• Foundayo: tablets.
• Wegovy: injections or tablets.
• Zepbound: the KwikPen only. Single-dose vials and pens are not covered through the Bridge.

That last distinction is exactly the sort of detail that produces an expensive surprise. A familiar brand name does not guarantee the package in front of you is the covered version. Ask the prescriber to write for a formulation on Medicare’s current list, and ask the pharmacy to process it through the Bridge.

There is another important dividing line. If your Medicare drug plan already covers your GLP-1 medicine, you are not eligible for this separate program. People with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease also are not eligible on the basis of those conditions; Medicare says their regular Part D plan may cover a GLP-1 treatment instead.

Approval still takes a clinician

A qualifying number on a chart does not create automatic pharmacy coverage. Your doctor or other qualified clinician must send a prescription and, when Medicare requests it, complete a prior authorization. The clinician must also certify that you are using the medicine with a lifestyle program focused on diet and exercise.

Once approved, Medicare says the prior authorization remains valid for refills and dose changes through December 31, 2027—unless you switch to a different GLP-1 drug. If you change medicines, expect a new coverage review. You should receive a letter confirming Bridge coverage.

This is also where I would slow down any sales pitch. A legitimate pharmacy may need your Medicare number or the last four digits of your Social Security number to process the prescription. That does not make it safe to give those numbers to an ad, an unsolicited caller, or a website that says it can “pre-approve” you. Begin with your own clinician and pharmacy.

What the $50 does not do

The copay is $50 for one 28- or 30-day supply, but Medicare treats it outside your regular drug benefit. According to the official cost rules:

• It does not count toward your Part D deductible.
• It does not count toward your annual Part D out-of-pocket limit.
• Extra Help cannot reduce it.
• The Medicare Prescription Payment Plan cannot spread it across later months.

You also will not see the payment on a Part D Explanation of Benefits or a Medicare Summary Notice. Keep the pharmacy receipt and coverage letter together so you have your own record of the drug, date, and amount.

The $50 is only the medication copay. Appointments, tests, or other services connected with treatment can have separate costs depending on your coverage and provider. Ask what monitoring is medically needed, whether Medicare covers it, and what you are likely to owe before scheduling it.

How to start cleanly

If the rules sound like they may fit, use this sequence:

1. Confirm drug coverage: Find your Medicare drug-plan card. Original Medicare without Part D is not enough for the Bridge.
2. Gather the facts: Write down your current height and weight and the qualifying condition documented in your medical record.
3. Ask your clinician: Discuss whether treatment is appropriate and, if so, which covered drug and formulation should be prescribed. Ask the office to complete prior authorization when requested.
4. Check the status: If the pharmacy cannot process the prescription, call 1-800-MEDICARE (1-800-633-4227) and ask about GLP-1 Bridge eligibility or prior authorization.

Do not pay a membership, application, or “enrollment” fee to reach this benefit. Medicare’s eligibility screen is free, and the approval path runs through your clinician, pharmacy, and Medicare. That is the clean route I would want my own family to use.

RETIREMENT INCOME

Your first required withdrawal can create a two-year squeeze

If you were born in 1953, 2026 is generally the first year a required minimum distribution applies to your traditional IRAs. The IRS lets you delay that first withdrawal until April 1, 2027—but your second withdrawal is still due by December 31, 2027. Waiting can put two taxable distributions into the same year (IRS required-distribution rules).

That does not make delaying wrong. It makes the tax effect worth estimating now, while there is time to choose. Roth IRAs have no lifetime required withdrawal for the original owner. A current employer’s plan may let a still-working participant wait, but traditional IRAs do not get that working exception, and a plan can impose stricter terms.

Ask each custodian for its 2026 calculation, then compare taking the first distribution this year with bunching two into 2027. Missing the amount can trigger a 25% tax on the shortfall, reduced to 10% when corrected within two years. The IRS calculation uses your December 31, 2025 account balance and a life-expectancy factor; do not guess from the current balance.

RETIREMENT ROUNDUP

• Check pension withholding: The IRS Tax Withholding Estimator now reflects the enhanced senior deduction and can account for pension and Social Security income. If it shows too much or too little coming out of a pension or annuity, the change generally goes to the payer on Form W-4P—not to Social Security.
• Recognize a real Zelle refund: The FTC is sending July payments to eligible AH Media Group customers who were charged about $90 after “free” beauty or weight-loss trials and did not accept an earlier refund. There is no new claim form. A real payment arrives automatically through Zelle, and the FTC-listed administrator never charges a fee.

QUICK CHECK

Does the $50 Medicare GLP-1 Bridge copay move you closer to your Part D annual out-of-pocket limit?

ANSWER

No. The Bridge is separate from your regular drug coverage, so the $50 copay does not count toward your Part D deductible or annual out-of-pocket limit. Keep that distinction in mind when estimating your total drug spending for the year.

Written by Ellen Marsh

Retirement Shield is educational information only — not financial, tax, or legal advice. We will never ask you for an account number, Social Security number, password, or payment.